PPH holdings — VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) held 26 positions with net assets of $879M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 72.7% of the fund, led by LLY, NVS, MRK.
PPH top holdings
- LLY Eli Lilly & Co — 20.23% ($178M)
- NVS Novartis AG — 10.63% ($93.4M)
- MRK Merck & Co Inc — 9.85% ($86.6M)
- NVO Novo Nordisk A/S — 5.37% ($47.2M)
- ABBV AbbVie Inc — 4.57% ($40.2M)
- PFE Pfizer Inc — 4.51% ($39.6M)
- BMY Bristol-Myers Squibb Co — 4.47% ($39.3M)
- GSK GSK PLC — 4.42% ($38.9M)
- JNJ Johnson & Johnson — 4.35% ($38.3M)
- AstraZeneca PLC — 4.33% ($38.1M)
- MCK McKesson Corp — 4.12% ($36.3M)
- SNY Sanofi SA — 4.00% ($35.2M)
- COR Cencora Inc — 3.36% ($29.5M)
- HLN Haleon PLC — 3.09% ($27.2M)
- Teva Pharmaceutical Industries Ltd — 3.06% ($26.9M)
- TAK Takeda Pharmaceutical Co Ltd — 2.87% ($25.3M)
- ZTS Zoetis Inc — 2.10% ($18.5M)
- VTRS Viatris Inc — 1.10% ($9.63M)
- Jazz Pharmaceuticals PLC — 1.08% ($9.50M)
- AXSM Axsome Therapeutics Inc — 0.77% ($6.75M)
- CORT Corcept Therapeutics Inc — 0.50% ($4.43M)
- ELAN Elanco Animal Health Inc — 0.35% ($3.11M)
- State Street Global Advisors — 0.28% ($2.43M)
- OGN Organon & Co — 0.23% ($2.01M)
- BHC Bausch Health Cos Inc — 0.10% ($861K)
What are PPH's top 10 holdings?
LLY (20.2%), NVS (10.6%), MRK (9.8%), NVO (5.4%), ABBV (4.6%), PFE (4.5%), BMY (4.5%), GSK (4.4%), JNJ (4.4%), AstraZeneca PLC (4.3%).
How many stocks are in PPH?
VanEck Pharmaceutical ETF reported 26 holdings as of June 30, 2026.